Artwork

Content provided by The Center for Investigative Reporting and PRX, The Center for Investigative Reporting, and PRX. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Center for Investigative Reporting and PRX, The Center for Investigative Reporting, and PRX or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

America Goes Psychedelic, Again

50:58
 
Share
 

Manage episode 406704451 series 44456
Content provided by The Center for Investigative Reporting and PRX, The Center for Investigative Reporting, and PRX. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Center for Investigative Reporting and PRX, The Center for Investigative Reporting, and PRX or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Psychedelic drugs have been illegal for 50 years, but they’re trickling back into the mainstream because they show promise in helping treat post-traumatic stress disorder and other mental health challenges.

We begin the hour with reporter Jonathan A. Davis visiting Psychedelic Science 2023, the largest-ever conference on psychedelic drugs. It’s put on by the Multidisciplinary Association for Psychedelic Studies, an organization dedicated to legalizing MDMA (also known as ecstasy or molly) and other psychedelic drugs. Research shows that MDMA-assisted therapy can help treat depression and PTSD, and it’s moving toward approval by the U.S. Food and Drug Administration. Psychedelics were studied in the 1950s and ’60s as mental health treatments, but the war on drugs put a stop to research. Now, these drugs are gaining bipartisan support from politicians looking for solutions to the mental health crisis among veterans.

Then Reveal’s Michael I Schiller visits a group of veterans who are not waiting for psychedelic-assisted therapy to be approved by the federal government. They’ve joined a church founded by an Iraq War veteran who uses psychedelics as religious sacraments. Schiller accompanies them on a retreat in rural Texas, where they share the depths of their post-traumatic stress and the relief they’ve felt after psychedelic treatments. He also explores the risks involved in taking these drugs.

We close with an intimate audio diary from a woman in Oakland, California, who’s going through therapy with the one psychedelic drug that can be legally prescribed currently in the U.S.: ketamine. Ketamine started out as an anesthetic, but researchers found it can help with treatment-resistant depression when used in tandem with talk therapy. Ketamine can be dangerous if abused, but it also has helped people find relief from mental health issues. This story was produced by Davis.

This is an update of an episode that originally aired in October 2023.

  continue reading

547 episodes

Artwork

America Goes Psychedelic, Again

Reveal

120,905 subscribers

published

iconShare
 
Manage episode 406704451 series 44456
Content provided by The Center for Investigative Reporting and PRX, The Center for Investigative Reporting, and PRX. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Center for Investigative Reporting and PRX, The Center for Investigative Reporting, and PRX or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Psychedelic drugs have been illegal for 50 years, but they’re trickling back into the mainstream because they show promise in helping treat post-traumatic stress disorder and other mental health challenges.

We begin the hour with reporter Jonathan A. Davis visiting Psychedelic Science 2023, the largest-ever conference on psychedelic drugs. It’s put on by the Multidisciplinary Association for Psychedelic Studies, an organization dedicated to legalizing MDMA (also known as ecstasy or molly) and other psychedelic drugs. Research shows that MDMA-assisted therapy can help treat depression and PTSD, and it’s moving toward approval by the U.S. Food and Drug Administration. Psychedelics were studied in the 1950s and ’60s as mental health treatments, but the war on drugs put a stop to research. Now, these drugs are gaining bipartisan support from politicians looking for solutions to the mental health crisis among veterans.

Then Reveal’s Michael I Schiller visits a group of veterans who are not waiting for psychedelic-assisted therapy to be approved by the federal government. They’ve joined a church founded by an Iraq War veteran who uses psychedelics as religious sacraments. Schiller accompanies them on a retreat in rural Texas, where they share the depths of their post-traumatic stress and the relief they’ve felt after psychedelic treatments. He also explores the risks involved in taking these drugs.

We close with an intimate audio diary from a woman in Oakland, California, who’s going through therapy with the one psychedelic drug that can be legally prescribed currently in the U.S.: ketamine. Ketamine started out as an anesthetic, but researchers found it can help with treatment-resistant depression when used in tandem with talk therapy. Ketamine can be dangerous if abused, but it also has helped people find relief from mental health issues. This story was produced by Davis.

This is an update of an episode that originally aired in October 2023.

  continue reading

547 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide